Delivery Order SPE2DB20D3101-SPE2DB25FRUT4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,868.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,956.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor...
- The Defense Logistics Agency awarded a $3,073.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,292.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order under the company's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $2,252.25 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens on September 15, 2025, with completion scheduled for September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,592.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $2,266.83, with completion scheduled for September 16, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order for pharmaceutical products to support federal medical procurement needs. The award was issued on September 15, 2025, with performance based in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on September 2, 2025, with a contract value of $1,235.98 and completion date of September 3, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen Drug Corp's corporate...
- The Defense Logistics Agency (DLA) awarded a $3,603.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on September 9, 2025, with completion expected by September 10, 2025. This non-set-aside competitive award represents a single delivery order fulfilling pharmaceutical supply needs for military and federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,304.68 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on July 31, 2025, with completion targeted for August 1, 2025. This firm fixed-price, non-set-aside delivery order represents a purchase of pharmaceutical inventory to support military and federal healthcare needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the federal government...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUT4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,874.31 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on September 8, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under the company's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a wide range of medications, medical devices, and healthcare commodities to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal health systems. Trulicity, a diabetes medication, represents one of numerous pharmaceutical products routinely procured through this vehicle to meet military and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/8/25 |